Vanguard Group Inc Haemonetics Corp Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Vanguard Group Inc holds 4,953,332 shares of HAE stock, worth $251 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,953,332

Previous 5,099,621 2.87%

Holding current value

$251 Million

Previous $324 Million 14.04%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$56.04 - $74.77 $8.2 Million - $10.9 Million	-146,289 Reduced 2.87%	4,953,332 $370 Million
Q1 2025 May 09, 2025	SELL	$59.34 - $80.05 $4.73 Million - $6.39 Million	-79,767 Reduced 1.54%	5,099,621 $324 Million
Q4 2024 Feb 11, 2025	BUY	$71.16 - $93.38 $720,068 - $944,912	10,119 Added 0.2%	5,179,388 $404 Million
Q3 2024 Nov 13, 2024	BUY	$72.45 - $91.58 $2.07 Million - $2.62 Million	28,567 Added 0.56%	5,169,269 $415 Million
Q2 2024 Aug 13, 2024	SELL	$81.24 - $97.37 $20.8 Million - $25 Million	-256,628 Reduced 4.75%	5,140,702 $425 Million
Q1 2024 May 10, 2024	SELL	$71.24 - $85.35 $639,663 - $766,357	-8,979 Reduced 0.17%	5,397,330 $461 Million
Q4 2023 Feb 14, 2024	BUY	$80.59 - $92.61 $2.05 Million - $2.36 Million	25,451 Added 0.47%	5,406,309 $462 Million
Q3 2023 Nov 14, 2023	BUY	$82.56 - $93.49 $2.24 Million - $2.54 Million	27,146 Added 0.51%	5,380,858 $482 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $2.32 Million - $2.57 Million	28,725 Added 0.54%	5,353,712 $456 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $5.98 Million - $7.44 Million	82,151 Added 1.57%	5,324,987 $441 Million
Q4 2022 Feb 10, 2023	BUY	$73.85 - $86.14 $3.52 Million - $4.1 Million	47,641 Added 0.92%	5,242,836 $412 Million
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $11 Million - $13.6 Million	173,113 Added 3.45%	5,195,195 $385 Million
Q2 2022 Aug 12, 2022	BUY	$49.27 - $66.08 $5.53 Million - $7.41 Million	112,186 Added 2.28%	5,022,082 $327 Million
Q1 2022 May 13, 2022	BUY	$43.77 - $63.22 $1.27 Million - $1.83 Million	28,960 Added 0.59%	4,909,896 $310 Million
Q4 2021 Feb 14, 2022	SELL	$49.55 - $74.59 $324,156 - $487,967	-6,542 Reduced 0.13%	4,880,936 $259 Million
Q3 2021 Nov 12, 2021	SELL	$57.6 - $70.59 $11,692 - $14,329	-203 Reduced -0.0%	4,887,478 $345 Million
Q2 2021 Aug 13, 2021	BUY	$51.81 - $118.56 $253 Million - $579 Million	4,887,681 New	4,887,681 $326 Million

Others Institutions Holding HAE

# of Institutions

335

Shares Held

53.7M

Call Options Held

540K

Put Options Held

306K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.6B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Haemonetics Corp Transaction History